---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-000199"
form_type: "8-K"
ticker: "ITGR"
cik: "0001114483"
company_name: "Integer Holdings Corp"
filed_at: "2024-01-10T23:59:59+00:00"
generated_at: "2026-06-07T00:50:45.736445+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Integer acquires Pulse Technologies for ~$140M; prelim FY2023 sales up 16% to ~$1.596B

## Summary
- Preliminary Q4 2023 sales $411-413M (+10-11% YoY); full-year sales $1.595-1.597B (+16% YoY).
- Acquired Pulse Technologies, a micro-machining contract manufacturer, for ~$140M plus contingent consideration.
- Pulse had ~$42M sales and ~$11M adj. EBITDA in 2023; deal closed Jan 5, 2024 using revolving credit facility.
- Integer expects deal to be accretive and stay within 2.5x-3.5x leverage target.
- Conference call for full Q4/FY results scheduled Feb 15, 2024.

## SEC filing metadata
- accession: 0001171843-24-000199
- form_type: 8-K
- ticker: ITGR
- cik: 0001114483
- company_name: Integer Holdings Corp
- filed_at: 2024-01-10T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1114483/000117184324000199/0001171843-24-000199-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1114483/000117184324000199/f8k_011024.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-000199
- JSON: https://secwatch.observer/filing/0001171843-24-000199.json
- Plain text: https://secwatch.observer/filing/0001171843-24-000199.txt

## Key facts
- Earnings Releases
  Integer Holdings Corp reported fourth quarter and year ended December 31, 2023 results: revenue $411 million to $413 million.
  - Period: fourth quarter and year ended December 31, 2023
  - Revenue: $411 million to $413 million
  - Result: preliminary results
  source text: Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced fourth quarter 2023 preliminary unaudited sales are expected to be in the range of $411 million to $413 million, an increase of 10% to 11% compared to fourth quarter 2022. Preliminary unaudited full year 2023 sales are expected to be in the range of $1.595 billion to $1.597
  evidence_url: https://www.sec.gov/Archives/edgar/data/1114483/000117184324000199/0001171843-24-000199-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.